Royalty Pharma RPRX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $586.4M-5.2% | $618.7M-34.1% | $938.94M+48.6% | $631.91M-41.9% | $1.09B+17.1% | ||
| $21.9M+16.5% | $18.8M+16.8% | $16.1M+22.0% | $13.2M+9.1% | $12.1M-79.2% | ||
| $20.04B-2.0% | $20.46B+1.8% | $20.09B+3.4% | $19.44B+0.1% | $19.41B+2,377% | ||
| $1.43B-6.7% | $1.53B-17.4% | $1.85B+21.7% | $1.52B-17.5% | $1.84B+2.3% | ||
| $924.63M0.0% | $924.63M0.0% | $924.63M0.0% | $924.63M— | —— | ||
| $173.27M+1.1% | $171.31M+32.4% | $129.39M+17.1% | $110.53M-21.7% | $141.08M-24.5% | ||
| $19.82B+1.0% | $19.62B+1.4% | $19.35B+5.6% | $18.32B+4.1% | $17.61B-3.4% | ||
| $25.48M+31.3% | $19.4M-53.1% | $41.42M+105% | $20.21M-46.3% | $37.63M+181% | ||
| $380M0.0% | $380M0.0% | $380M-62.0% | $999.44M+0.1% | $998.61M+0.1% | ||
| $535.68M-15.8% | $636.21M+19.9% | $530.8M-56.0% | $1.21B+2.0% | $1.18B-5.6% | ||
| $8.58B+0.1% | $8.57B+0.1% | $8.57B+22.3% | $7B+5.8% | $6.62B+0.1% | ||
| $9.88B-0.3% | $9.91B+1.8% | $9.73B+10.3% | $8.82B+12.8% | $7.82B-0.8% | ||
| $2.51B+6.4% | $2.36B+2.3% | $2.3B+3.7% | $2.22B-10.4% | $2.48B-12.8% | ||
| $9.94B+2.3% | $9.71B+1.0% | $9.62B+1.2% | $9.5B-2.8% | $9.78B-5.5% | ||
| $19.82B+1.0% | $19.62B+1.4% | $19.35B+5.6% | $18.32B+4.1% | $17.61B-3.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Royalty Pharma's total assets?
- Royalty Pharma (RPRX) holds $19.8B in total assets, up 12.5% year over year.
- How much debt does Royalty Pharma have?
- Royalty Pharma carries $9.0B in total debt against $9.9B of shareholders' equity, a debt-to-equity ratio of 0.90.
- How much cash does Royalty Pharma have?
- Royalty Pharma holds $586.4M in cash and equivalents.
- Can Royalty Pharma cover its short-term obligations?
- Its current ratio is 2.66 — current assets exceed current liabilities.
- Where does Royalty Pharma's balance sheet data come from?
- Every line is extracted from Royalty Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
